HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 12.06
+0.38 (3.25%)
At close: Mar 6, 2026
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 10.08 billion as of March 6, 2026. Its market cap has increased by 247.52% in one year.
Market Cap
10.08B
Enterprise Value
8.08B
Revenue
908.35M
Ranking
n/a
PE Ratio
16.68
Stock Price
12.06
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 10.08B, an increase of 19.11%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.08B | -0.88% |
| Dec 31, 2025 | 10.17B | 646.35% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 14.14B |
| Everest Medicines | 12.51B |
| Guangzhou Innogen Pharmaceutical Group | 10.39B |
| Nanjing Leads Biolabs | 9.95B |
| Shanghai Haohai Biological Technology | 9.86B |
| CStone Pharmaceuticals | 8.69B |
| CK Life Sciences Int'l., (Holdings) | 7.59B |
| Alphamab Oncology | 7.55B |